Clinical trials: Restenosis

Coronary Heart Disease, Coronary Restenosis

Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents

• Completed
• Age: 18 years and older
• Phase 4
• Pill or oral medicine
• Medical device
• Results posted

In a previous randomized comparison oral sirolimus plus bare metal stent compared to bare metal stent implantation alone demonstrated at one year of follow up a significant reduction of angiographic and clinical parameters of…

Trial name

ORAR III (NCT00552669)

Testing

Oral sirolimus, Drug Eluting stent

Where

3 sites in Argentina

Volunteers

200 people

Sponsor

Centro de estudios en Cardiologia Intervencionista